# Dome-Type: A Distinctive Variant of Colonic Adenocarcinoma

Authors: Giacomo Puppa; Mariella Molaro
Journal: Case Reports in Pathology
 (2012)

---

## Abstract

Introduction. Ten cases of dome-type adenocarcinoma of the colon have been reported so far. Most of them were presented as early lesions, with endoscopic and microscopic distinguishing features. Methods and Results. A raised plaque was removed from the right colon during colonoscopy in a 56-year-old man. Histopathological examination showed a cancerized adenoma invading the submucosa with several  typical features of dome-type adenocarcinoma, in particular the associated prominent lymphoid tissue. Immunohistochemistry showed retention of the mismatch repair proteins MLH-1, MSH-2, MLH-6, and PMS-2. Conclusion. We report an additional case of dome-type adenocarcinoma of the colon as an early, low-risk, and microsatellite stable tumor, indicating that this particular histotype may deserve specific consideration for both classification and management.


---

## Body

## 1. Introduction

Since the initial reports back in late 90’s & 2000’s by De Petris et al.  [1] and Jass et al.  [2] 10 cases of dome-type (DC) adenocarcinoma of the colon have been reported [1–7]. DC is considered a rare variant of carcinoma of the colon presenting as a nonpolypoid plaque lesion, it is thought to derive from the specialized columnar M-cells of dome epithelium, which makes up in association with the gut-associated lymphoid tissue the domelike masses that bulge into the gut lumen [2].Originating from this specific microenvironment, the most important morphological feature of DC is the association with a prominent lymphoid stroma.We would like to add an additional case of this particular histotype that was recently diagnosed in our institute.


## 2. Case Presentation

A 56-years male with amyotrophic lateral sclerosis was colonoscoped because of painful constipation. There was no case of colorectal cancer in  his family history.An 8-mm raised plaque was seen in the right flexure (Figure1) and removed.Figure 1
Conventional endoscopic image showing the dome-like lesion. A reddish rough mucosa can be seen in the top surface.Routine histopathological examination showed a cancerized adenoma invading the submucosa associated with expanded lymphoid tissue encompassing several reactive germinal centres (Figures2(a), 2(b), and 2(c)).(a) Panoramic view of the tumor described. A well-demarcated tumor grows into the submucosa (hematoxylin-eosin, ×10). Overlying mucosa shows adenoma with high-grade dysplasia. Invasive adenocarcinoma associated with prominent lymphoid tissue encompassing several reactive germinal centres is observed in the submucosal layer. (b) Pan-Cytokeratin highlight tumor invasion. From the advancing edge few scattered foci of tumor budding arise (Cytocheratin AE1-3 ×20). (c) Histological architecture encompassing cystically dilated glands, in part cribriform arranged (hematoxylin-eosin, ×50). (d) The pink eosinophilic material filling the more dilated glands; a clear space separates the glandular epithelium from the intraglandular material (hematoxylin-eosin, ×200).
(a)
(b)
(c)
(d)The cancer, arisen in a flat adenoma with high-grade dysplasia, was ulcerated superficially and the advancing edge appeared quite well circumscribed except for a more submucosa-invading tongue of neoplastic glands where some low-grade budding was observed (Figures2(a), 2(b) and 2(c)).The glands were in part cystically dilated containing a pink eosinophilic material, in part cribriform arranged (Figures2(c) and 2(d)).A clear space often separates the glandular epithelium from the intraglandular material.Neoplastic cells lining the glands were columnar, single-layered, well-differentiated, eosinophilic (Figure2(d)).No tumor infiltrating lymphocytes nor goblet cells were observed. Necrosis and desmoplasia also were absent.The T1 adenocarcinoma was considered a low-risk lesion because of the absence of lymphovascular invasion, the low-differentiation grade, and the negative resection margin, therefore no hemicolectomy was performed.Immunohistochemistry showed retained expression of the mismatch repair proteins MLH-1, MSH-2 MSH-6, and PMS-2 in the neoplastic cells as well in the internal control (Figures3(a), 3(b), 3(c), and 3(d), resp.).Immunohistochemical analysis of MLH-1, MSH-2, MSH-6, and PMS-2 protein expression in the DC. The neoplastic cells and the internal control  (lymphocytes) are positive (a) for MLH-1 (×40), (b) for MSH-2 (×40), (c) for MSH-6 (×40), and (d) for PMS-2 (×40).
(a)
(b)
(c)
(d)The patient underwent a follow-up colonoscopy one year later: the mucosal biopsies from the polypectomy site showed at histology mild fibroinflammatory changes.


## 3. Discussion

DC may develop as sporadic-type colon cancer or in association with ulcerative colitis, [6] familial adenomatous polyposis, [2] hereditary nonpolyposis colorectal cancer, [1] and other positive family history of colorectal cancer, [2, 5] in both right and left colon, therefore DC is not associated to any specific mechanisms of tumour predisposition.Some distinguishing features both macroscopic and microscopic are constantly present: the nonpolypoid appearance, the cell architecture, the cytology, and the presence of prominent lymphoid tissue; other features such as the tumor infiltrating lymphocytes, the intra-acinar necrosis, the remnants of a preexisting adenoma and foci of usual-type adenocarcinoma of the colon may be present or absent.Most cases are reported in the early growth phase: eight over ten case reported are T1N0, [1–6] one is T2N0 [3], and the last one is T3N0 [7]. No recurrence is documented so far and the patient presented with this report is one-year recurrence-free.The case reported here of DC is another early and low-grade lesion, lacking features of biological aggressiveness, microsatellite stable tumor, suggesting that this particular histotype may deserve a space in the classification of tumors of the colon and rectum.In the management of neoplastic colonic polyps DCper se may identify a low-risk malignant lesion, influencing the treatment decision-making process.



---

*Source: 284064-2012-11-19.xml*